Research programme: oxazolidinone antibacterials - Orchid

Drug Profile

Research programme: oxazolidinone antibacterials - Orchid

Alternative Names: OCID 0050; OCID0619; Oxazolidinone antibacterials research programme - Orchid

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Orchid Chemicals & Pharmaceuticals
  • Class Oxazolidinones
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Bacterial-infections in India
  • 19 Sep 2011 Preclinical antimicrobial data presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2011)
  • 31 Dec 2004 Preclinical antimicrobial data presented at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2004) ,
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top